NCCN Oncology Research Program (ORP)
NCCN Puma Neratinib Research Grant Opportunity: submit by Monday, April 19, 2021
Study Proposal Submission-NCCN iEnvision
NCCN AstraZeneca NSCLC Research Opportunity: submit LOIs by Monday, May 3, 2021
ORP Scientific Publications
ORP Investigator Steering Committee
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
NCCN Insights: Analytics, Research & Consulting
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees
NCCN Research & Business Resources

NCCN Oncology Research Program (ORP) Recent News
The NCCN Oncology Research Program (ORP) facilitates all phases of clinical research by identifying investigators and initiating clinical trials at NCCN Member Institutions. The NCCN ORP draws on the expertise of investigators at 28 leading cancer centers and establishes collaborations with pharmaceutical and biotechnology companies in order to advance therapeutic options for patients with cancer. To date, the NCCN ORP has provided almost $30 million in research funding to investigators at NCCN Member Institutions. Click on a press release below to learn more about the NCCN ORP.
NCCN Oncology Research Program (ORP) News Archive
Please select a year to view our archived press releases:
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2003
2002
For questions about NCCN or to request an interview, please contact Rachel Darwin, darwin@nccn.org.
|